56 related articles for article (PubMed ID: 27307025)
1. Sample size requirements for case-control study designs.
Edwardes MD
BMC Med Res Methodol; 2001; 1():11. PubMed ID: 11747473
[TBL] [Abstract][Full Text] [Related]
2. Trial Design Challenges and Approaches for Precision Oncology in Rare Tumors: Experiences of the Children's Oncology Group.
Renfro LA; Ji L; Piao J; Onar-Thomas A; Kairalla JA; Alonzo TA
JCO Precis Oncol; 2019; 3():. PubMed ID: 32923863
[TBL] [Abstract][Full Text] [Related]
3. Group sequential design for historical control trials using error spending functions.
Wu J; Li Y
J Biopharm Stat; 2020 Mar; 30(2):351-363. PubMed ID: 31718458
[TBL] [Abstract][Full Text] [Related]
4. Limitations of randomized clinical trials. Proposed alternative designs.
Cleophas TJ; Zwinderman AH
Clin Chem Lab Med; 2000 Dec; 38(12):1217-23. PubMed ID: 11205684
[TBL] [Abstract][Full Text] [Related]
5. Design of randomized controlled trials.
Stanley K
Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
[No Abstract] [Full Text] [Related]
6. Survival trial design and monitoring using historical controls.
Wu J; Xiong X
Pharm Stat; 2016 Sep; 15(5):405-11. PubMed ID: 27307025
[TBL] [Abstract][Full Text] [Related]
7. Two-stage optimal designs based on exact variance for a single-arm trial with survival endpoints.
Shan G
J Biopharm Stat; 2020 Sep; 30(5):797-805. PubMed ID: 32129130
[TBL] [Abstract][Full Text] [Related]
8. Trial of penicillamine in advanced primary biliary cirrhosis.
Dickson ER; Fleming TR; Wiesner RH; Baldus WP; Fleming CR; Ludwig J; McCall JT
N Engl J Med; 1985 Apr; 312(16):1011-5. PubMed ID: 3885033
[TBL] [Abstract][Full Text] [Related]
9. Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.
Neuberger J; Christensen E; Portmann B; Caballeria J; Rodes J; Ranek L; Tygstrup N; Williams R
Gut; 1985 Feb; 26(2):114-9. PubMed ID: 3881323
[TBL] [Abstract][Full Text] [Related]
10. Sample size adjustment designs with time-to-event outcomes: A caution.
Freidlin B; Korn EL
Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
[TBL] [Abstract][Full Text] [Related]
11. Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls.
Yuan J; Liu J; Zhu R; Lu Y; Palm U
J Biopharm Stat; 2019; 29(3):558-573. PubMed ID: 30612514
[TBL] [Abstract][Full Text] [Related]
12. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.
Guyot P; Ades AE; Ouwens MJ; Welton NJ
BMC Med Res Methodol; 2012 Feb; 12():9. PubMed ID: 22297116
[TBL] [Abstract][Full Text] [Related]
13. Calculating sample size in trials using historical controls.
Zhang S; Cao J; Ahn C
Clin Trials; 2010 Aug; 7(4):343-53. PubMed ID: 20573638
[TBL] [Abstract][Full Text] [Related]
14. Analysis of 29 consecutive thoracoscopic repairs of congenital diaphragmatic hernia in neonates compared to historical controls.
Cho SD; Krishnaswami S; Mckee JC; Zallen G; Silen ML; Bliss DW
J Pediatr Surg; 2009 Jan; 44(1):80-6; discussion 86. PubMed ID: 19159722
[TBL] [Abstract][Full Text] [Related]
15. Successful outcomes of EMR-L with 3D-EUS for rectal carcinoids compared with historical controls.
Abe T; Kakemura T; Fujinuma S; Maetani I
World J Gastroenterol; 2008 Jul; 14(25):4054-8. PubMed ID: 18609690
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
